BONESUPPORT AB is a Scandinavian orthobiologics company that develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodeling to host bone in six to twelve months.
Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.
Latest Press Release
CERAMENT® G AND CERAMENT® V contributes to improved survival rates
2025-01-07
Change in BONESUPPORT’s Nomination Committee ahead of the 2025 Annual General Meeting following a change in ownership
2024-11-29
Change in number of shares and votes in BONESUPPORT HOLDING AB (publ)
2024-11-29